See also this year's filing and all EDGAR filings for this company.
PDF Report 0001302573_2015_Oncomed_Pharmaceuticals_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001302573, Oncomed Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 240,810,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 5,104,000 |
| 3 | remainder_Assets | 1,928,000 |
| 4 | LiabilitiesCurrent | 38,546,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 132,929,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 13,753,000 |
| 9 | ResearchAndDevelopmentExpense | 76,430,000 |
| 10 | remainder_Expenses | -509,000 |
| 11 | remainder_Revenues | 39,559,000 |
| 12 | remainder_NetIncome | 105,000 |
| 13 | remainder_ComprehensiveNetIncome | -31,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 247,842,000 |
| 1 | Liabilities | 171,475,000 |
| 2 | Expenses | 89,674,000 |
| 3 | Revenues | 39,559,000 |
| 4 | StockholdersEquity | 76,367,000 |
| 5 | NetIncome | -50,010,000 |
| 6 | ComprehensiveNetIncome | -50,025,500 |
| 7 | BaseVar | 274,343,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.555 |
| 9 | EconomicCapitalRatio | 1.93 |
Edgar->Model Mapping
Feature Distribution
Change over Time
